Preparing for the Unfathomable: Staying ahead of AI
Generative AI is just one strand of artificial intelligence which is progressing at enormous speed, already pushing the boundaries of deep research, with profound implications…
Generative AI is just one strand of artificial intelligence which is progressing at enormous speed, already pushing the boundaries of deep research, with profound implications…
For pharmaceutical manufacturers, patents are vital stepping stones that allow companies to recover large investments and fuel future research and breakthroughs. They motivate manufacturers to…
Arriello’s Sam Tomlinson reviews the findings of new US/EU research charting biotech efforts to expand their market globally. The biotech market was estimated to be…
The biotech industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing, and real-time analytics reshaping drug discovery, personalised medicine, and healthcare…
Drug development designed to treat rare disease is both a noble cause and a risky business. Rare diseases are typically deadly, debilitating, and devastating for…
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts….
How AI is advancing and transforming future cancer medical treatments and how a cure for cancer may be closer than we think. AI is transforming…
While opportunities for continuing education and Pharma-sponsored learning programs are always welcome by healthcare providers (HCPs), it is no secret that traditional HCP education is…
Delphine Perridy, Chief Commercial Officer at Envirotainer explores six essential predictions shaping pharmaceutical logistics and cold chain for the year ahead. The pharmaceutical cold chain…
To advance science without compromising trial efficiency, we must prioritise simpler user journeys and connected data. Clinical trials are constantly pushing the boundaries of innovation….